• A Hybrid Conference and Internet Event
• Sponsored by International Society of Healthcare Compliance Professionals
• Co-sponsored by the Pharmaceutical Compliance Forum
• Held May 21 - 23, 2013
• Onsite at the Meliá Castilla Hotel, Madrid, Spain
• In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
• www.InternationalPharmaCongress.com

WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE™ -- APRIL 17, 2013: The Seventh International Pharmaceutical Compliance Congress, www.InternationalPharmaCongress.com, will take place on May 21 - 23, 2013 at the Meliá Castilla Hotel in Madrid, Spain. Registrants may attend the event in person or online (live webcast and archived for 6 months).

GABOR DANIELFY MEMORIAL KEYNOTE ADDRESS Elvira Sanz President, Pfizer Spain, President, Farmaindustria, Madrid, Spain

ETHICS KEYNOTE ADDRESS Marc Le Menestrel, PhD Visiting Professor of Ethics, INSEAD, Associate Professor, University Pompeu Fabra (Barcelona), Barcelona, Spain

TRANSFORMING THE COMPLIANCE PROFESSION KEYNOTE ADDRESS Arthur Muratyan, Esq. Secretary General and Board Member, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Former Vice President-Head of Legal Corporate, and Global Compliance Officer, Sanofi, Paris, France

TRANSPARENCY INT'L KEYNOTE ADDRESS Huguette Labelle, CC, PhD, LLD Chair, Transparency International, Companion of the Order of Canada, Berlin, Germany

OTHER KEYNOTE SPEAKERS Reinhard Angelmar, PhD Salmon and Rameau Fellow of Healthcare, Management Professor of Marketing, INSEAD, Appointments, Sloan School (MIT), Stockholm School of Economics, ESSEC Business School, and Universite Paris Dauphine, Fontainebleau, France Carl H. Coleman, JD Professor of Law and Director of Global Initiatives, Center for Health & Pharmaceutical Law & Policy and Gibbons, Institute of Law, Science & Technology, Seton Hall University School of Law, Former Bioethics and Law Adviser, World Health Organization (WHO), Newark, NJ Jose F. Zamarriego Izquierdo Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain Tamara Music Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland Marie-Claire Pickaert Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium Heather Simmonds Director and Chair, Code of Practice Panel, Prescription Medicines Code of Practice Authority, London, UK Andy Powrie-Smith Director for Trust and Reputation, Association of the British Pharmaceutical Industry (ABPI), London, UK

A SPECIAL COMPLIMENTARY, INVITATION-ONLY SPANISH COMPLIANCE ROUNDTABLE On Tuesday, May 21, 2013 immediately prior to the Congress Sponsored by FARMAINDUSTRIA FEATURING

Arancha Burgos Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain Santiago Páramo Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain Olga Sanz Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain Julián Zabala Head of Communications, FARMAINDUSTRIA, Madrid, Spain Jose F. Zamarriego Izquierdo Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain (Moderator) Click here to request invitation to attend.

PLENARY SESSIONS Business Ethics for Pharma and Device Companies Roundtable on Integrating Ethics Theory into Ethics Practice Global Anticorruption Roundtable EU Transparency Roundtable Compliance Issues and Congresses The Role of the International Society of Healthcare Ethics and Compliance Professionals (ethics) Compliance as a Profession: Common Body of Knowledge, Training, Professional Ethics and Professional Certification INTERNATIONAL PHARMA CONGRESS IS AND MINI SUMMITS Mini Summit I: Basic Compliance Training Mini Summit II: Global Auditing and Monitoring Best Practices I Mini Summit III: Annual MEA Compliance Roundtable Mini Summit IV: Social Media, Apps and eDigital Space Mini Summit V: Crucial Compliance Resources And Non-Material Support For Compliance Officers Mini Summit VI: INSEAD Case Study Mini Summit VII: Annual CEE Compliance Update Mini Summit VIII: Advanced Issues In Global Transparency Mini Summit IX: Global Compliance Issues And Initiatives In The Medical Device Sector Mini Summit X: Global Anti-Bribery Compliance Mini Summit XI: Global Auditing and Monitoring Best Practices II Mini Summit XII: Global Compliance Issues Update Mini Summit XIII: Public Procurement and Pharma Pricing Update Mini Summit XIV: Global Compliance Codes Update Mini Summit XV: Pre- And Post-Transaction Due Diligence For Compliance Mini Summit XVI: Making Use Of Case Studies As An Educational Tool Mini Summit XVII: Achilles Heel in Managing Global Corruption and Preventing Your Initiative's Downfall

ETHICS UPDATE Michael Hercz, Esq. Director, Audit and Enterprise Risk Services, Deloitte & Touche LLP; Former Vice President and Chief Compliance Officer, Victory Pharmaceuticals, Inc., Costa Mesa, CA, USA Dan Ostergaard Founder and Chief Executive Officer, Integrity by Design, Former Head of Corporate Integrity and Compliance, Novartis AG, Basel, Switzerland Guido Palazzo, PhD Professor of Business Ethics, University of Lausanne, Visiting Fellow, Universities of Nottingham and Oxford, Member, Editorial Boards, Business Ethics Quarterly, and Business & Society, Lausanne, Switzerland Andy Powrie-Smith Director for Trust and Reputation, Association of the British Pharmaceutical Industry (ABPI), London, UK Lori Queisser Principal, Advisory Services, KPMG LLP, Former Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Former Member, PCF Executive Committee, Indianapolis, IN, USA Paul B. Woods, BPharm, MA, MRPharmS Independent Consultant; Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK

GLOBAL ANTICORRUPTION UPDATE Peter Dieners, Esq. Partner, Clifford Chance, Düsseldorf, Germany Gerry Fujimoto, CPA Partner, Forensic & Dispute Services, Deloitte Financial Advisory Services, LLP, San Francisco, CA Gary F. Giampetruzzi, Esq. Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA Edward F. Hanover, Esq. General Counsel, Novo Nordisk Region International Operations A/S, Zurich, Switzerland Marc L. Miller Partner, KPMG LLP, New York, NY, USA Lewis Morris, Esq. Senior Counsel, Adelman, Sheff and Smith LLC, Former Chief Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Annapolis, MD, USA Edward A. Rial, JD Partner and Global Leader, FCPA Consulting Services, Deloitte Financial Advisory Services LLP; Former Assistant US Attorney, US Attorney's Office, Eastern District of New York, New York, NY Vivian Robinson, Esq. Partner, McGuireWoods; Former General Counsel of the UK Serious Fraud Office; Former Head, QEB Hollis Whiteman Chambers; Recorder of the Crown Court and Treasurer of Inner Temple, London, UK Joseph B. Tompkins, Jr. Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA Juan Valderas Partner, Forensic & Dispute Services, Deloitte Financial Advisory Services, LLP, Madrid, Spain Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France (Moderator)

GLOBAL TRANSPARENCY UPDATE Dr. Michael Bartke Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Co-chair, EFPIA Compliance Workgroup, Munich, Germany Andy Bender, MS, MBA President, Polaris, New York, NY, USA Carsten Blaesberg Chief Consultant, Lif Denmark, The Danish Association of the Pharmaceutical Industry, Copenhagen, Denmark Julie Bonhomme, Esq. Legal Manager, Legal and Compliance Department, LEEM, Paris, France William E. Buzzeo, MS Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA Daniel A. Kracov, Esq. Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC, USA Evelyne Lemaire Director, Global Pharmaceutical and Life Sciences, PwC LLP, Zurich, Switzerland Andrew Parks Director, KPMG, McLean, VA, USA Heather Simmonds Director, Prescription Medicines Code of Practice Authority, London, UK Matthijs M. van Blokland, Esq. General Counsel, Prosensa, General Counsel and Senior Policy Advisor Legal Affairs, Association Innovative Medicines, Nefarma, Board Member, Stichting CGRz, Amsterdam, The Netherlands

GLOBAL COMPLIANCE ISSUES AND CODES UPDATES John Auerbach, MA Partner, Fraud Investigation and Dispute Services, Ernst & Young, Shanghai, China Bulent Becan Managing Partner, Atuva Management Consultancy, and Trade Ltd.; Consultant in Ethics Issues, Turkish Research Based, Pharmaceutical Companies Association (AIFD), Istanbul, Turkey Joe Henein President and Chief Executive Officer, NewBridge Pharmaceuticals, Former Regional Managing Director, Middle East, and North Africa, Wyeth Pharmaceuticals, Dubai, United Arab Emirates Vivian Lima-Barnett OEC Director, Latin America, Abbvie, Co-chair, Latin American Pharma Congress, Abbott Park, IL, USA Juan Francisco Millán Soberanes, MD Secretary and Executive Director, CETIFARMA, Mexico City, Mexico Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA

GLOBAL COMPLIANCE ISSUES IN THE MEDICAL DEVICE SECTOR Suzanne Durdevic, DEA, LLM Senior Director, General Counsel, EMEA, Boston Scientific International; Chair, Legal Affairs Group, EUCOMED, Paris, France Anthony McQuillan, Esq. Vice President Legal and Compliance EMEA, Medtronic; Chair, EUCOMED Code Committee, Tolochenaz, Switzerland Elisabethann Wright, Esq. Partner, Hogan Lovells; Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium Brian Riewerts Partner, Global Pharmaceuticals and Life Sciences, PwC LLP Baltimore, MD, USA (Co-moderator) Roeland Van Aelst Vice President EMEA & Canada, Health Care Compliance and Privacy, Johnson & Johnson; Board Member and Co-chair, Strategic Committee, International Society of Healthcare Ethics and Compliance Professionals (ethics), Brussels, Belgium (Co-moderator)

CONGRESSES AND REALITIES: CROSS-BORDER CONFLUENCE, TERRITORIAL ISSUES VS. GLOBAL ACTIVITIES, MIXING IFPMA/EFPIA CODES WITH CONGRESS AND SOCIETY RULES Marie-Claire Pickaert Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium Jeff Rosenbaum Vice President, Chief Compliance Officer, Vertex Pharmaceuticals, Former Executive Director, Global Head of Ethics & Compliance Novartis Oncology, Boston, MA Debra C. Forster, Esq. Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland Christian-Claus Roth Head of Congresses and Conventions, Novartis Pharma; Co-President, International Pharmaceutical Congress Advisory Association (IPCAA), Basel, Switzerland Ann Beasley Bacon Vice President Corporate Compliance, International, Biogen Idec International, GmbH (as of March 1); Former Global Compliance Officer, Novartis Pharma AG; Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Zug, Switzerland (Moderator)

BASIC COMPLIANCE TRAINING Sue Egan Director and Principal Consultant, Sue Egan Associates, Editor, Life Science Compliance, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

CRUCIAL COMPLIANCE RESOURCES Tomasz Kruk, LL M, MBA Director Global Ethics and Compliance, Actavis, Zug, Switzerland

EMERGING COMPLIANCE ISSUES: SOCIAL MEDIA, APPS AND eDIGITAL SPACE Bulent Becan Managing Partner, Atuva Management Consultancy and Trade Ltd., Consultant in Ethics Issues, Turkish Research Based Pharmaceutical Companies Association (AIFD), Istanbul, Turkey Noelia de Miguel, PhD, Esq. Senior Associate and Head of Life, Sciences Regulatory Spain, Hogan Lovells International LLP, Madrid, Spain Denise Silber President, Basil Strategies Digital Consultancy and Organizers, Doctors 2.0 & You Conference, Paris, France Philippe Cloarec European Ethics and Compliance Associate - CCEP-I, Eli Lilly and Company, Geneva, Switzerland (Moderator)

BEST PRACTICES IN GLOBAL AUDITING AND COMPLIANCE MANAGEMENT SYSTEMS Yogesh Bahl, MBA Partner, National Practice Leader - Life Sciences, Deloitte Financial Advisory Services LLP, New York, NY, USA Andy Bender, MS, MBA President, Polarism New York, NY, USA L. Stephan Vincze, JD, LLM, MBA Director, Audit and Enterprise, Risk Services, Deloitte & Touche LLP; Former Vice President, Ethics & Compliance Officer and Privacy Officer, TAP Pharmaceutical Products Inc., Boston, MA, USA (Moderator)

THIRD PARTY AUDITS George Fife Director, EMEA Compliance and Ethics, Bristol-Myers, Squibb, Paris, France Michele Tagliaferri, Esq. Counsel, Sidley Austin LLP, Brussels, Belgium Melda Tanyeri, MS, MBA Senior Manager, Fraud Investigation and Dispute Services, Ernst & Young LLP, Paris, France

PRE- AND POST-TRANSACTION DUE DILIGENCE Brian E. Kowalski, Esq. Associate, Latham & Watkins, Washington, DC, USA Greg Crouse Principal, Ernst & Young LLP, Moscow, Russia (Moderator)

COMPLIANCE CASE STUDIES Nancy A. Grygiel, LD, LLM Senior Director, International Business Compliance, Allergan, Irvine, CA, USA Jonathon Kellerman Principal, Pharmaceutical and Life, Sciences Advisory Services, PwC LLP, Florham Park, NJ, USA (Co-moderator) Gerard Geneen Vice President, Compliance Officer, Pharma Europe GlaxoSmithKline, Brentford, Middlesex, United Kingdom (Co-moderator)

CENTRAL AND EASTERN (CEE) UPDATE Oleksiy Bezhevets, JD, MBA Partner, ARCA Law Firm; Partner, Legal Alliance Company, Ukraine Paul J. Melling, Esq. Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia Mariusz Witalis Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland (Moderator)

MIDDLE EAST AFRICA (MEA) UPDATE Hulya Baran Director, Ethics and Compliance TMEA - CIS, Eli Lilly and Company, Istanbul, Turkey Meltem Ozker Gunduz Legal Affairs and Compliance Director, Business Area Near East, Novo Nordisk, Istanbul, Turkey Liz MacGillivray Compliance Director, Anti-Bribery, Country Support & Monitoring, Group Integrity and Compliance, Novartis International AG, Basil, Switzerland Laura Nassar Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson, Beirut, Lebanon Joe Henein President and Chief Executive Officer, NewBridge Pharmaceuticals, Former Regional Managing Director, Middle East, and North Africa, Wyeth Pharmaceuticals, Dubai, United Arab Emirates (Moderator)

COMPLIANCE ISSUES FOR SMALL-MID SIZE PHARMA AND BIOTECH COMPANIES Maurits J.F. Lugard, MA, JD, LLM Partner, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium John Patrick Oroho, Esq. Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC; Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA

EFFECTIVE MANAGEMENT OF CROSS-BORDER EXPERT ENGAGEMENTS Wayne Baker Senior Vice President and Chief Sales Officer, AHM, New Providence, NJ, USA Iain Holloway-McLean Medical Operations Director, GlaxoSmithKline, Brentford, UK

SPECIAL SPANISH STAKEHOLDERS ROUNDTABLE Dra. Begoña Barragán President, Spanish Group of Cancer Patients, Madrid, Spain Dr. Antonio Cachá Deputy Director General for Evaluation and Control, Healthcare Ministry of the Regional Government, Community of Madrid, Madrid, Spain Dra. Neus Rams I Pla Deputy Director General of Pharmacy and Sanitary Products, Generalitat de Catalunya, Barcelona, Spain Dr. Miguel Ángel Caracuel Ruiz Vice-President, Spanish Federation of Scientific Medical Associations, Científico Médicas Españolas (FACME), Madrid, Spain

SAVE THE DATE
FIFTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND A Hybrid Conference and Internet Event February 19 - 21, 2013 The Ritz-Carlton Washington, DC www.DisclosureSummit.com	SEVENTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS A Hybrid Conference and Internet Event Sponsored by International Society of Healthcare Compliance Professionals Cosponsored by Pharmaceutical Compliance Forum May 21 - 23, 2013 Meliá Castilla Hotel Madrid, Spain www.InternationalPharmaCongress.com
THIRD ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS A Hybrid Conference and Internet Event Sponsored by Asia Pacific Healthcare Industry Compliance Team Cosponsored by Pharmaceutical Compliance Forum September 10 - 12, 2013 Kuala Lumpur, Malaysia www.AsianPharmaCongress.com	FOURTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS A Hybrid Conference and Internet Event Sponsored by Pharmaceutical Compliance Forum October 28 - 30, 2013 Hyatt Regency on Capitol Hill Washington, DC www.PharmaCongress.com